UDP-N-acetyl-.alpha.-D-galactosamine: polypeptide N-acetylgalact

Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Transferase other than ribonuclease

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 691, 4352523, 4353201, 435 6, 536 232, 536 243, 536 2431, 530350, C12N 910, C12N 120, C12P 2106, C07H 2104

Patent

active

058719903

ABSTRACT:
A novel gene defining a novel enzyme in the UDP-N-acetyl-.alpha.-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase family, termed GalNAc-T3, with unique enzymatic properties is disclosed. The enzymatic activity of GalNAc-T3 is shown to be distinct from that of two previously identified enzymes of this gene family. The invention discloses isolated DNA molecules and DNA constructs encoding GalNAc-T3 and derivatives thereof by way of amino acid deletion, substitution or insertion exhibiting GalNAc-T3 activity, as well as cloning and expression vectors including such DNA, cells transfected with the vectors, and recombinant methods for providing GalNAc-T3. The enzyme GalNAc-T3 and GalNAc-T3-active derivatives thereof are disclosed, in particular soluble derivatives comprising the catalytically active domain of GalNAc-T3. Further, the invention discloses methods of obtaining N-acetylgalactosamine glycosylated peptides or proteins by use of an enzymically active GalNAc-T3 protein or fusion protein thereof or by using cells stably transfected with a vector including DNA encoding an enzymatically active GalNAc-T3 protein as an expression system for recombinant production of such glycopeptides or glycoproteins. Also a method for the production of a vaccine by modifying the O-glycosylation pattern of an eukaryotic cell, and a method for the identification of DNA sequence variations in the GalNAc-T3 gene by isolating DNA from a patient, amplifying GalNAc-T3-coding exons by PCR, and detecting the presence of DNA sequence variation, are disclosed.

REFERENCES:
patent: 5177015 (1993-01-01), Matsuura et al.
Clausen, et al., Complex Carbohydrates in Drug Research, Alfred Benzon Symposium, "Simple mucin type O-glycans of HIV: Enzymatic prediction of glycosylation sites for vaccine construction," 36:297-315, 1994.
Sorensen, et al., J. Biol. Chem., UDP-N-acetyl-.alpha.-D-galactosamine:polypeptide N-Acetylgalactosaminyltransferase, 270(41):24166-24173,1995.
White, et al., J. Biol. Chem., Purification and cDNA and Cloning of a Human UDP-N-acetyl-.beta.-D-galatosamine:polypeptide N-Acetylgalatosaminyltransferase, 270(41):24156-24165, 1995.
Matsuura, et al., J. Biol. Chem., "An .alpha.-N-Acetylgalactosaminylation at the Threonine Residue of a Defined Peptide Sequence Creates the Oncofetal Peptide Epitode in Human Fibronectin," 264(18):10472-10476, 1989.
Matsuura, et al., J. Biol. Chem., "The Oncofetal Structure of Human Fibronectin Defined by Monoclonal Antibody FDC-6," 263(7):3314-3322, 1988.
Hagen, et al., J. Biol. Chem., Purification, Cloning, and Expression of a Bovine UDP-GalNAc: Polypeptide N-Acetylgalactosaminyltransferase, 268(25):18960-18965, 1993.
Homa, et al., J. Biol. Chem., Isolation and Expression of a cDNA Clone Encoding a Bovine UDP-GalNAc: Polypeptide N-Acetylgalactosaminyltransferase, 268(17), pp. 12609-12616, 1993.
Grunnet, et al., Vox Sang., "Evaluation of Histo-Blood Group ABO Genotyping in a Danish Population: Frequency of a Novel O Allele Defined as O.sup.2," 67:210-215, 1994.
Luo, et al., Am. J. Hum. Genet., "Affected-Sib-Pair Mapping of a Novel Susceptibility Gene to Insulin-Dependent Diabetes Mellitus (IDDM8) on Chromosome 6q25-q27," 57:911-919, 1995.
Copeman, et al.,Nature Genetics, Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33, 9:80-85, 1995.
Goodfellow, et al., Nature, "From the simple to the complex," 371:104-105, 1994.
Bennett, et al., Biochem. and Biophys. Res. Comm., "Genomic Cloning of the Human Histo-Blood Group ABO Locus," 206(1):318-325, 1995.
EMBL, Database GenBank/DDBJ, accession No., X92689, Sequence HSGNT3, Apr. 30, 1996, Bennett, E.P. et al.
Bennett, E.P. et al., J. Biol. Chem. 271:17006-17012, Jul. 19, 1996.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

UDP-N-acetyl-.alpha.-D-galactosamine: polypeptide N-acetylgalact does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with UDP-N-acetyl-.alpha.-D-galactosamine: polypeptide N-acetylgalact, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and UDP-N-acetyl-.alpha.-D-galactosamine: polypeptide N-acetylgalact will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2061548

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.